stockrowLifecore Biomedical, Inc. (LFCR) vs Siga Technologies Inc. (SIGA)
- Lifecore Biomedical, Inc. LFCR 6.37 −0.47%
- Siga Technologies Inc. SIGA 3.10 +4.38%
Lifecore Biomedical, Inc. and Siga Technologies Inc. are both Drug Manufacturers Specialty & Generic companies. Lifecore Biomedical, Inc. is the larger, with a market value of $242.6M against $213.4M — 1.1× the size. Lifecore Biomedical, Inc. grew revenue faster over the last twelve months: −18.2% against −70.1%. Siga Technologies Inc. has the higher net margin (−5.19% vs −65.9%) and the lower return on invested capital (−14.6% vs 0.00%). Across the 17 metrics below, Lifecore Biomedical, Inc. leads on 11 and Siga Technologies Inc. on 6.
Valuation
Profitability
| Metric | LFCR | SIGA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 27.38% | 54.35% | 53.51% |
| Operating margin | (5.33%) | (20.76%) | 0.00% |
| Net margin | (65.91%) | (5.19%) | (2.45%) |
| Free cash flow margin | 9.86% | (37.58%) | 0.00% |
| Return on equity | 178.69% | (1.49%) | (0.80%) |
| Return on assets | (32.36%) | (1.36%) | (1.67%) |
| Return on invested capital | 0.00% | (14.59%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack